Zenas Biopharma Inc (ZBIO)
$28.39 -1.29% Close Oct 30, 2026 Live
Zenas Biopharma stock today
Zenas Biopharma closed at $28.39 on October 30, 2026, down 1.29% on the day. Over the past year it returned -5.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.79 billion.
$20.00$30.00$40.00
NovJan 2026MarMayJulSep
| Period | ZBIO | S&P 500 (SPY) |
|---|---|---|
| 1 month | +5.3% | -0.9% |
| 3 months | -12.0% | +2.1% |
| Year to date | -21.8% | +11.7% |
| 1 year | -5.0% | +12.4% |
Key statistics
- Market value
- $1.79B
- 52-week range
- $15.20 to $43.17
- Next report
- Nov 12, 2026 (estimated)
About Zenas Biopharma
Biopharmaceutical company developing therapies for immunological and inflammatory diseases.
Sector: Health Care
More on Zenas Biopharma
- Financials: revenue, earnings and segmentsRevenue +100% in the year to Dec 2025
- Returns: what $1,000 became$1,000 one year ago is $950.13 today
No forecast, no recommendation. This page describes Zenas Biopharma Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.